Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Osteoarthritis Cartilage. 2018 Aug 23;26(12):1658–1665. doi: 10.1016/j.joca.2018.08.005

Table 3.

Association of inflammatory biomarkers (LBP and sTLR4) with knee osteoarthritis progression (adjusted for treatment group, BMI and baseline outcome variable*).

Outcome Variable Biomarker n Parameter Estimate (SE) or Odds Ratio*** (95% CI) p Value
Z-LBP baseline 341 −7.08×10−2 (4.18×10−2) 0.090
ΔJSW16 Z-TIC (LBP)12 253 −1.11×10−1 (5.21×10−2) 0.035
Z-TIC (LBP)18 282 −7.90×10−2 (4.79×10−2) 0.100

Z-LBP baseline 341 1.319 (1.029, 1.692) 0.029
JSN16 Z-TIC (LBP)12 253 1.406 (1.042, 1.898) 0.026
Z-TIC (LBP)18 282 1.418 (1.06, 1.897) 0.019

Log10 (ΔuCTX-Il18)** Z-sTLR4 baseline
Z-TIC (sTLR4)18
234
233
1.98×10−3 (6.25×10−4)
1.71×10−3 (5.48×10−4)
0.0017
0.0021

Biomarker Data were Z score transformed.

*

Covariates include treatment group, age, BMI, and corresponding baseline radiographic measures (JSW baseline for ΔJSW16; uCTX-II at baseline for ΔuCTX-II18)

**

log ((Δ uCTX-II18) was based on log10((Δ uCTX-II18+1-min((Δ uCTX-II18 for the cohort)).

***

Odds ratios only given for logistic regression models. Others are beta coefficient parameter estimates and standard error (SE) from linear regression for continuous outcomes. p<0.05 in bold